Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Bentley Pharmaceuticals Inc (BNT) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Bentley Pharmaceuticals Inc. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 821616.
Total stock buying since 2005: $155,657.
Total stock sales since 2005: $0.
Total stock option exercises since 2005: $962,625.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2008 | 0 | $0 | 0 | $0 | 80,153 | $16,625 |
| 2007 | 0 | $0 | 0 | $0 | 11,889 | $0 |
| 2006 | 5,000 | $49,250 | 0 | $0 | 200,000 | $946,000 |
| 2005 | 9,000 | $106,407 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2008-06 | 0 | $0 | 0 | $0 | 24,715 | $0 |
| 2008-05 | 0 | $0 | 0 | $0 | 31,438 | $16,625 |
| 2008-01 | 0 | $0 | 0 | $0 | 24,000 | $0 |
| 2007-06 | 0 | $0 | 0 | $0 | 714 | $0 |
| 2007-05 | 0 | $0 | 0 | $0 | 11,175 | $0 |
| 2006-11 | 5,000 | $49,250 | 0 | $0 | 0 | $0 |
| 2006-03 | 0 | $0 | 0 | $0 | 200,000 | $946,000 |
| 2005-06 | 9,000 | $106,407 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2008-06-30 | Hebert Robert P (Other) | Option Ex | 715 | .00 | 0 |
| 2008-06-02 | Robinson Edward J (Director) | Option Ex | 8,000 | .00 | 0 |
| 2008-06-02 | Johnson F Ross (Director) | Option Ex | 8,000 | .00 | 0 |
| 2008-06-02 | Mcgovern Michael (Director) | Option Ex | 8,000 | .00 | 0 |
| 2008-05-23 | Hebert Robert P (Other) | Option Ex | 763 | .00 | 0 |
| 2008-05-23 | Sedor John A (President) | Option Ex | 5,800 | .00 | 0 |
| 2008-05-23 | Herrera Malaga Adolfo (Other) | Option Ex | 4,375 | .00 | 0 |
| 2008-05-23 | Murphy James R (Chairman & CEO) | Option Ex | 11,250 | .00 | 0 |
| 2008-05-23 | Lindsay Richard P (VP and CFO) | Option Ex | 2,250 | .00 | 0 |
| 2008-05-22 | Herrera Malaga Adolfo (Other) | Option Ex | 7,000 | 2.38 | 16,625 |
| 2008-01-02 | Robinson Edward J (Director) | Option Ex | 8,000 | .00 | 0 |
| 2008-01-02 | Johnson F Ross (Director) | Option Ex | 8,000 | .00 | 0 |
| 2008-01-02 | Mcgovern Michael (Director) | Option Ex | 8,000 | .00 | 0 |
| 2007-06-30 | Hebert Robert P (Other) | Option Ex | 714 | .00 | 0 |
| 2007-05-23 | Sedor John A (President) | Option Ex | 2,300 | .00 | 0 |
| 2007-05-23 | Herrera Malaga Adolfo (Other) | Option Ex | 2,125 | .00 | 0 |
| 2007-05-23 | Murphy James R (Chairman & CEO) | Option Ex | 6,750 | .00 | 0 |
| 2006-11-09 | Spiegel John W (Director) | Buy | 5,000 | 9.85 | 49,250 |
| 2006-03-23 | Murphy James R (Chairman & CEO) | Option Ex | 200,000 | 4.73 | 946,000 |
| 2005-06-09 | Spiegel John W (Director) | Buy | 9,000 | 11.82 | 106,407 |
Insider trading activities including stock purchases, stock sales, and option exercises of BNT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Bentley Pharmaceuticals Inc (symbol BNT, CIK number 821616) see the Securities and Exchange Commission (SEC) website.